Minnesota Medicaid and tirzepatide
Zepbound for weight loss: yes. Prior authorization. Adults: BMI 30 or higher, or BMI 27 or higher with a weight-related condition. Ages 12 to 17: BMI 30 or higher and body weight above 60 kg. Diet and activity documentation; at least 5% weight loss to renew. Mounjaro for weight loss: not confirmed. The May 2026 Uniform PDL lists Mounjaro as nonpreferred under hypoglycemics, which does not answer weight loss. The anti-obesity list does not name it, and absence is not a no. No Mounjaro-specific criteria could be read; other mn.gov criteria pages returned a bot check.; for type 2 diabetes Minnesota Medicaid must cover it. Read from Minnesota Department of Human Services documents Nov 6, 2026.
In 2025 Minnesota Medicaid paid for 49,251 tirzepatide prescriptions (Zepbound, Mounjaro), 21% of its GLP-1 prescriptions and 12th of the 50 states and DC. It reimbursed $51.0 million before rebates, $1,036 a prescription against $1,032 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Zepbound | 31,424 | $32.6 million | $1,039 |
| Mounjaro | 17,827 | $18.4 million | $1,032 |
Minnesota plans and prescribing rules
Minnesota Advantage Health Plan (SEGIP). Minnesota's Advantage Health Plan, in its 2026 Summary of Benefits, excludes weight-loss drugs unless they are medically necessary, appropriate treatment and part of a Plan-approved program.
Tirzepatide in the states around Minnesota
| State | Sell tirzepatide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Zepbound for weight loss |
|---|---|---|---|---|
| Minnesota | 17 | $69/moWellmedr | 49,251 | Medicaid Zepbound: Yes |
| Iowa | 17 | $69/moWellmedr | 22,499 | Medicaid Zepbound: No |
| North Dakota | 15 | $69/moWellmedr | 67 | Medicaid Zepbound: No |
| South Dakota | 17 | $69/moWellmedr | 7,486 | Medicaid Zepbound: No |
| Wisconsin | 17 | $69/moWellmedr | 118,120 | Medicaid Zepbound: Yes |



